NCT00109135已完成2 期
A Double-Blind, Multicenter, Randomized, Titrated-Dose, Placebo-Controlled, Study of MK0364 (4 mg to 8 mg) in Chronic Cigarette Smokers as an Aid for Smoking Cessation
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 300
- 主要终点
- Quitting smoking after 8 weeks of treatment by measuring lab values and expired breath CO levels
研究概览
简要总结
The purpose of this study is to evaluate the safety and tolerability of an investigational drug that may help individuals to stop smoking.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Smoking greater than/equal to 10 cigarettes/day for at least 1 year
- •Laboratory tests that meet the criteria of the study
- •In overall good health as determined by the investigator
排除标准
- •Psychiatric diagnoses
- •Certain cancers
- •Patients who use nicotine replacement therapy
- •Patients on a diet regimen
结局指标
主要结局
Quitting smoking after 8 weeks of treatment by measuring lab values and expired breath CO levels
时间窗: after 8 weeks of treatment
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
A Healthy Subject Study With Z-360 and PlaceboHealthy VolunteersNCT01776463Zeria Pharmaceutical43
已完成
1 期
Safety and Tolerability of ACU-4429HealthyNCT00703183Kubota Vision Inc.46
已完成
2 期
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With SchizophreniaSchizophreniaNCT01377233H. Lundbeck A/S46
已完成
1 期
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative ColitisUlcerative ColitisNCT01759056Avaxia Biologics, Incorporated33
已完成
1 期
First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult VolunteersHealthy VolunteersNCT01011296Pfizer24